Targeting serotonin transporter boosts tumor-fighting T cells
Cell · 2025
DOI: 10.1016/j.cell.2025.06.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2025. Verfasst von Michael D Gershon. Beteiligte Einrichtung: Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University, 630 West 168(th) Street, New York, NY 1003…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Neoplasms, Serotonin Plasma Membrane Transport Proteins. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NINDS NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University, 630 West 168(th) Street, New York, NY 10032, USA. Electronic address: mdg4@cumc.columbia.edu.
Förderung
- NIDDK NIH HHS
- NINDS NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Gershon, M. D. (2025). Targeting serotonin transporter boosts tumor-fighting T cells. Cell. https://doi.org/10.1016/j.cell.2025.06.012
Vancouver
Gershon MD. Targeting serotonin transporter boosts tumor-fighting T cells. Cell. 2025. doi:10.1016/j.cell.2025.06.012
BibTeX
@article{Gershon2025,
author = {Gershon, Michael D},
title = {Targeting serotonin transporter boosts tumor-fighting T cells},
journal = {Cell},
year = {2025},
doi = {10.1016/j.cell.2025.06.012}
}
EUVIMED